dc.contributor.author | Sönmez, HE | |
dc.contributor.author | Demirkan, Fatma Gül | |
dc.contributor.author | Koç, R | |
dc.contributor.author | Çakmak, Figen | |
dc.contributor.author | Ayaz, Nuray | |
dc.contributor.author | Karadağ, ŞG | |
dc.date.accessioned | 2021-03-02T17:43:01Z | |
dc.date.available | 2021-03-02T17:43:01Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Ayaz N., Karadağ Ş., Koç R., Demirkan F. G. , Çakmak F., Sönmez H., "Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study", Rheumatology International, cilt.40, sa.7, ss.1111-1116, 2020 | |
dc.identifier.issn | 0172-8172 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_fbc3bd85-7942-43c5-a080-485b3efcaf27 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/4333 | |
dc.identifier.uri | https://doi.org/10.1007/s00296-020-04596-3 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085508800&origin=inward | |
dc.language.iso | eng | |
dc.title | Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study | |
dc.type | Makale | |
dc.relation.journal | Rheumatology International | |
dc.contributor.department | , , | |
dc.identifier.volume | 40 | |
dc.identifier.issue | 7 | |
dc.identifier.startpage | 1111 | |
dc.identifier.endpage | 1116 | |
dc.contributor.firstauthorID | 839733 | |